2025-03-12 13:22:34
Latest Post
W S Industries India Ltd's subsidiary to acquire 54.89 acres land for Rs. 46.66 crores
IKS Health wins Top Honors in 2025 Black Book Survey in New AI-Driven RCM Category
Mipco Seamless Rings Gujarat Ltd approves shifting of registered office
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Stock Report
Anuh Pharma Ltd posts net profit of Rs. 9.30 crores in Q3FY23
Posted On : 2023-02-11 22:40:46( TIMEZONE : IST )
ANUH PHARMA LTD. has reported Standalone financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 140.8425 crores during the period ended December 31, 2022 as compared to Rs. 117.0795 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 9.3061 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 9.9152 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 1.86 for the period ended December 31, 2022 as compared to Rs. 1.98 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹140.8425 crs | ₹117.0795 crs |  20.30% |
| Net Profit | ₹9.3061 crs | ₹9.9152 crs |  -6.14% |
| EPS | ₹1.86 | ₹1.98 | -6.06% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.140.8425 crores during the period ended December 31, 2022 as compared to Rs.132.0029 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.9.3061 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.7.4480 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.1.86 for the period ended December 31, 2022 as compared to Rs.1.49 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹140.8425 crs | ₹132.0029 crs | 6.70% |
| Net Profit | ₹9.3061 crs | ₹7.4480 crs | 24.95% |
| EPS | ₹1.86 | ₹1.49 | 24.83% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.375.2535 crores during the 9 Months period ended December 31, 2022 as compared to Rs.361.8446 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.26.5566 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.21.6357 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.5.30 for the 9 Months period ended December 31, 2022 as compared to Rs.4.32 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹375.2535 crs | ₹361.8446 crs | 3.71% |
| Net Profit | ₹26.5566 crs | ₹21.6357 crs | 22.74% |
| EPS | ₹5.30 | ₹4.32 | 22.69% |
Shares of ANUH PHARMA LTD. was last trading in BSE at Rs. 88.40 as compared to the previous close of Rs. 88.80. The total number of shares traded during the day was 7903 in over 137 trades.
The stock hit an intraday high of Rs. 89.80 and intraday low of 88.10. The net turnover during the day was Rs. 699337.00.
